Skip to main content
CDC Website

Viral Hepatitis

Addressing Social Determinants of Health: Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STD and TB External Consultation December 9-10, 2008: Atlanta, Georgia, Meeting Report

This report summarizes the external consultation on appropriate key short - and long-term priorities for addressing social determinants of HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP) to undertake.

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention: Annual Report Fiscal Year 2008

This report from the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) describes its activities for the year 2008. It provides its history, mission, and key priorities, which are reducing health disparities, encouraging program collaboration and service integration, and maximizing global synergies. The report reviews program accomplishments and scientific findings for 2008 and provides a summary of the NCHHSTP budget showing where the funds were spent. The appendix explains the performance measures for NCHHSTP and the progress that is being made.

Disease Burden from Viral Hepatitis A, B, and C in the United States

This report contains surveillance data on the incidence of viral hepatitis A, B, and C in the United States. It lists the number of acute clinical cases reported, estimated number of acute clinical cases, estimated number of new infections, number of persons living with chronic infection, annual number of chronic liver disease deaths associated with viral hepatitis, and percentage of persons ever infected with hepatitis A, B, and C for the years 2002 to 2007.

MMWR: National, State, and Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2008

This report provides information on the National Immunization Survey (NIS) which estimated vaccination coverage among children aged 19-35 months for 50 states and selected local areas. It describes the 2008 NIS coverage estimates for the 4:3:1:3:3:1 series and individual vaccines, 7-valent pneumococcal conjugate vaccine, =2 dose of Hepatitis A vaccine, and hepatitis B vaccine among children born during January 2005 - June 2007. Results demonstrate that the nation’s immunization program remained successful in maintaining high vaccination rates among young children.

Syringe Exchange Programs – United States, 2008

This study discusses information on the 184 syringe exchange programs (SEPs) operating in 36 states, the District of Columbia, and Puerto Rico. Of these SEPs, 67% completed a mail/telephone survey conducted by North American Syringe Exchange Network (NASEN) and Beth Israel Medical Center, New York, which covered program operations for 2008. The report summarizes findings from the survey and compares them with results from a previous SEP survey for 1994-2007.

Hepatitis A Vaccination Coverage Among U.S. Children Aged 12-23 Months–Immunization Information System Sentinel Sites, 2006–2009

In this study, CDC reports on assessed hepatitis A vaccine coverage among children aged 12-23 months from 2006-2009, using data from eight Immunization Information System sentinel sites. Average hepatitis A vaccination coverage with =1 dose at the sites increased from 17 percent in 2006 to 47 percent in 2009. Average full vaccination coverage with =2 vaccine doses through age 23 months increased from one percent in 2006 to 15 percent in 2009. Vaccine coverage with =1 dose increased most during 2006 through the first quarter of 2007, then slowed.

MMWR: Evaluation of Acute Hepatitis C Infection Surveillance – United States, 2008

This report describes CDC comparison of acute hepatitis C virus (HCV) surveillance data reported in 2008 from the National Notifiable Diseases Surveillance System (NNDS) and the Emerging Infections Program (EIP), which conducts enhanced surveillance for acute hepatitis C in selected states. Results show that 26 of 120 cases reported from EIP-funded sites were missing from NNDSS. Data on race and major HCV risk factors were missing from 22 percent and 60 percent of reports in NNDSS, compared with 8 percent and 25 percent of reports in EIP, respectively.

Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C

This report contains recommendations by the Committee on the Prevention and Control of Viral Hepatitis Infections of the National Academies of the Institute of Medicine, on prevention and control of hepatitis B and hepatitis C in the United States. The committee identified the underlying factors that impede current efforts to prevent and control these diseases.

Hepatitis B at Usang Malusog Na Sanggol

This slide set is an audiovisual educational tool that explains the importance of getting babies vaccinated against hepatitis B. It discusses hepatitis transmission, testing for the pregnant woman to determine if she has hepatitis B, and routine hepatitis B vaccine for babies.